XYNOS KONSTANTINOS (Chief Medical Officer) sold 5.1% of their position (7.95K shares) of REPLIMUNE GROUP, INC. on the open market
Open‑market sale worth $64.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/22/2025ACC: 0001104659-25-052145
Officer· Chief Medical Officer
Since Dec 2022
-7.95K
Net shares
Net seller
$64.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.95K
Price / share
$8.06
Trade value
$64.09K
% of position
5.1%
5/20/2025
154.88K→146.93K
Total
Net shares
−7.95K
Net value
-$64.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/20/2025 | S · Sale | −7.95K | $8.06 | $64.09K | 5.1% | 154.88K | 146.93K |
| Total | −7.95K | -$64.09K | ||||||
Derivative Transactions0
No derivative transactions reported